https://www.news-medical.net/news/20230124/New-study-evaluates-the-safety-profile-of-the-BNT162b2-vaccine-in-New-Zealand.aspx
Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.
Create an account or login to join the discussion